09/02/2026
Still measuring your PBM performance by rebates?
That number looks great in a report. It doesn't always match what you're actually paying.
As pharmacy costs climb and specialty drugs eat more of the budget, more plan sponsors are moving past rebate-chasing and focused on what actually drives cost: net cost.
Join Seubert and our pharmacy consulting partner, Navion, for a free 45-minute virtual roundtable on the PBM strategies shaping 2027 renewals, including biosimilars, GLP-1 coverage, specialty drug spend, and PBM transparency.
If you own benefits strategy or your company's healthcare spend, this one's for you. Register here: https://www.seubert.com/blog/net-cost-wins-how-plan-sponsors-are-leaving-rebates-behind/